Search research articles
Contact Us
Filters
Showing results (231-240 of 272) with videos related to
Page
of 28
Sort By:
Blood
|
May 17, 2003
High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis
Ajay K Gopal, Theodore A Gooley, David G Maloney, et al.
Blood
|
February 7, 2012
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
Brian G Till, Michael C Jensen, Jinjuan Wang, et al.
Medical Physics
|
July 3, 2015
Quantitative single-particle digital autoradiography with α-particle emitters for targeted radionuclide therapy using the iQID camera
Brian W Miller, Sofia H L Frost, Shani L Frayo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2013
A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine--tositumomab
Oliver W Press, Joseph M Unger, Lisa M Rimsza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2018
Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus <sup>131</sup>I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016
Mazyar Shadman, Hongli Li, Lisa Rimsza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 27, 2014
Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndrome
Raya Mawad, Ted A Gooley, Joseph G Rajendran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2011
Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma
Steven I Park, Jaideep Shenoi, Shani M Frayo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2012
Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016
Oliver W Press, Joseph M Unger, Lisa M Rimsza, et al.
Blood
|
April 20, 2002
High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma
Ajay K Gopal, Joseph G Rajendran, Stephen H Petersdorf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 3, 2014
Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation
Ryan D Cassaday, Barry E Storer, Mohamed L Sorror, et al.
Page
of 28
Search research articles
Search
Showing results (231-240 of 272) with videos related to
Sort By:
Page
of 28
Blood
|
May 17, 2003
High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable cohort analysis
Ajay K Gopal, Theodore A Gooley, David G Maloney, et al.
Blood
|
February 7, 2012
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
Brian G Till, Michael C Jensen, Jinjuan Wang, et al.
Medical Physics
|
July 3, 2015
Quantitative single-particle digital autoradiography with α-particle emitters for targeted radionuclide therapy using the iQID camera
Brian W Miller, Sofia H L Frost, Shani L Frayo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 17, 2013
A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP + 131iodine--tositumomab
Oliver W Press, Joseph M Unger, Lisa M Rimsza, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 23, 2018
Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus <sup>131</sup>I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016
Mazyar Shadman, Hongli Li, Lisa Rimsza, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
May 27, 2014
Radiolabeled anti-CD45 antibody with reduced-intensity conditioning and allogeneic transplantation for younger patients with advanced acute myeloid leukemia or myelodysplastic syndrome
Raya Mawad, Ted A Gooley, Joseph G Rajendran, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2011
Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma
Steven I Park, Jaideep Shenoi, Shani M Frayo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 13, 2012
Phase III randomized intergroup trial of CHOP plus rituximab compared with CHOP chemotherapy plus (131)iodine-tositumomab for previously untreated follicular non-Hodgkin lymphoma: SWOG S0016
Oliver W Press, Joseph M Unger, Lisa M Rimsza, et al.
Blood
|
April 20, 2002
High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma
Ajay K Gopal, Joseph G Rajendran, Stephen H Petersdorf, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
December 3, 2014
Long-term outcomes of patients with persistent indolent B cell malignancies undergoing nonmyeloablative allogeneic transplantation
Ryan D Cassaday, Barry E Storer, Mohamed L Sorror, et al.
Page
of 28